Clinical Cancer Research | American Association for Cancer Research

Skip Nav Destination

Current Issue

Volume 31,

Issue 2

15 January 2025

About the Journal

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics. Read More About the Journal

Editor-in-Chief

Keith T. Flaherty

View Full Editorial Board

Impact Factor

10.4

SUBMIT TO JOURNAL

Featured Articles

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Randy F. Sweis, et al.

Targeting T-Cell Costimulation to the Surface of Tumor Cells

Iñaki Eguren-Santamaría; Miguel F. Sanmamed; Paula Molero-Glez; Jose Luis Perez-Gracia; Ignacio Melero

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers

Young Kwang Chae, et al.

Trending - Altmetric

The article titled, CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation, has an Alt Metric Attention Score of 11. Click to see more of this article's metrics.

Read the article titled, CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation

Last mentioned on Wednesday January 22 2025

$The article titled, Enhancement Of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma., has an Alt Metric Attention Score of 16.08. Click to see more of this article's metrics.$